These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21505104)

  • 21. FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.
    Ma Q; Fu W; Li P; Nicosia SV; Jenster G; Zhang X; Bai W
    Mol Endocrinol; 2009 Feb; 23(2):213-25. PubMed ID: 19074551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1.
    Zhang X; Wu H; Dobson JR; Browne G; Hong D; Akech J; Languino LR; Stein GS; Lian JB
    J Cell Biochem; 2015 Sep; 116(9):2098-108. PubMed ID: 25808168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.
    Yang Y; Bai Y; He Y; Zhao Y; Chen J; Ma L; Pan Y; Hinten M; Zhang J; Karnes RJ; Kohli M; Westendorf JJ; Li B; Zhu R; Huang H; Xu W
    Clin Cancer Res; 2018 Feb; 24(4):834-846. PubMed ID: 29167276
    [No Abstract]   [Full Text] [Related]  

  • 24. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.
    Dey P; Jonsson P; Hartman J; Williams C; Ström A; Gustafsson JÅ
    Mol Endocrinol; 2012 Dec; 26(12):1991-2003. PubMed ID: 23028063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
    Kamo N; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2013 Jan; 57(1):289-98. PubMed ID: 22807038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization.
    Li XQ; Lu JT; Tan CC; Wang QS; Feng YM
    Cancer Lett; 2016 Sep; 380(1):78-86. PubMed ID: 27317874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.
    Mediwala SN; Sun H; Szafran AT; Hartig SM; Sonpavde G; Hayes TG; Thiagarajan P; Mancini MA; Marcelli M
    Prostate; 2013 Feb; 73(3):267-77. PubMed ID: 22821817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
    Yang Y; Hou H; Haller EM; Nicosia SV; Bai W
    EMBO J; 2005 Mar; 24(5):1021-32. PubMed ID: 15692560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of RhoC induces macrophage M1 polarization to inhibit migration and invasion in colon cancer via regulating the PTEN/FOXO1 pathway.
    Yang B; Wang L; Tian Z
    Int J Exp Pathol; 2023 Feb; 104(1):33-42. PubMed ID: 36576072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo.
    Nesbitt H; Browne G; O'Donovan KM; Byrne NM; Worthington J; McKeown SR; McKenna DJ
    J Cell Physiol; 2016 Feb; 231(2):473-82. PubMed ID: 26189652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deregulation of FOXO3A during prostate cancer progression.
    Shukla S; Shukla M; Maclennan GT; Fu P; Gupta S
    Int J Oncol; 2009 Jun; 34(6):1613-20. PubMed ID: 19424579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis.
    Teixeira CC; Liu Y; Thant LM; Pang J; Palmer G; Alikhani M
    J Biol Chem; 2010 Oct; 285(40):31055-65. PubMed ID: 20650891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.
    Lu H; Liu P; Pan Y; Huang H
    Neoplasia; 2011 Sep; 13(9):854-63. PubMed ID: 21969818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
    Kimbrough-Allah MN; Millena AC; Khan SA
    Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
    Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
    Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
    Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.
    Gan L; Chen S; Wang Y; Watahiki A; Bohrer L; Sun Z; Wang Y; Huang H
    Cancer Res; 2009 Nov; 69(21):8386-94. PubMed ID: 19826044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.